US Stock MarketDetailed Quotes

PTN Palatin Technologies

Watchlist
  • 1.8699
  • +0.2699+16.87%
Trading Mar 28 11:57 ET
30.17MMarket Cap-627P/E (TTM)

About Palatin Technologies Company

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Company Profile

SymbolPTN
Company NamePalatin Technologies
Listing Date12/21/1999
Issue Price9.00
Founded1986
CEODr. Carl Spana,PhD
MarketAMEX
Employees34
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
AddressCedar Brook Corporate Center,4-B Cedar Brook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-495-2200

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carl Spana,PhD
  • Chief Executive Officer, President and Director
  • 1.36M
  • Stephen Thomas Wills
  • Chief Financial Officer, Principal Accounting Officer, Chief Operating Officer, Executive Vice President, Secretary and Treasurer
  • 1.23M
  • Dr. John K.A. Prendergast,PhD
  • Non-Executive Chairman of the Board
  • 212.89K
  • Arlene M. Morris
  • Independent Director
  • 140.00K
  • Robert K. deVeer, Jr
  • Independent Director
  • 155.00K
  • Dr. Alan W. Dunton,M.D.
  • Independent Director
  • 155.00K
  • J. Stanley Hull
  • Independent Director
  • 145.00K
  • Dr. Anthony M. Manning, PhD
  • Independent Director
  • 140.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg